| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2840-203
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-15 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6897
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-92 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6897
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| filingDate |
1999-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d210d8d6698d7e2845bc14f65e5f1aa8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84878064f7c6c62d3e70ce591a4c0289
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6410a27c2f84d6abf699081984779cd1 |
| publicationDate |
2002-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2002137699-A1 |
| titleOfInvention |
Expression systems comprising chimeric promoters with binding sites for recombinant transcription factors |
| abstract |
Expression systems comprising chimeric promoters with binding sites for recombinant transcription factors The present invention relates to a nucleic acid construct which comprises the following components: n Component a): at least one promoter n Component b): a nucleic acid sequence encoding at least one recombinant transactivator whose transcription is activated by component a) and which comprises: n component b1): a nucleic acid sequence encoding a DNA-binding domain n component b2): a nucleic acid sequence encoding a transactivation domain comprising glutamine, serine and threonine n Component c): at least one a nucleic acid sequence sequence for binding the expression product of component b) n Component d): at least one promoter which comprises the CDE-CHR element or the E2FBS-CHR element and whose 5′ end is bound, i.e., linked, to the 3′ end of component c) n Component e): at least one effector gene whose transcription is activated by the expression product of component b) binding to component c); n to its preparation and its use; to vectors comprising the nucleic acid construct, cells comprising these vectors, and to the use of the nucleic acid construct for the preparation of a medicament. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009053295-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113462686-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007238123-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7235401-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2012225749-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004103067-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004248133-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9402919-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003157704-A1 |
| priorityDate |
1998-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |